 | In a comment letter to the Centers for Medicare and Medicaid Services (CMS), PIPC offered feedback on the agency's Transitional Coverage for Emerging Technologies (TCET) notice. |
The letter stresses the importance of patients gaining quick and easy access to new technologies without delays and barriers that can lead to further declines in their health. Specifically, we encourage CMS to consider the following comments to strengthen the TCET pathway and encourage more robust patient access to innovative technologies:
"PIPC appreciates CMS establishing the TCET pathway and taking steps to make innovative devices available to patients with fewer barriers to access," wrote PIPC Chair Tony Coelho. "We would encourage CMS to consider more robust avenues to meaningfully engage patients and to ensure this pathway provides broad meaningful access to novel technologies."
- There should be a more robust and formalized process for the patient perspective to be incorporated through the TCET process.
- CMS should clearly acknowledge and abide by the laws barring use of QALYs and similar measures as it refines the CED process.
- The TCET pathway should strive to make as many innovative technologies available to patients as possible
"PIPC appreciates CMS establishing the TCET pathway and taking steps to make innovative devices available to patients with fewer barriers to access," wrote PIPC Chair Tony Coelho. "We would encourage CMS to consider more robust avenues to meaningfully engage patients and to ensure this pathway provides broad meaningful access to novel technologies."
| pipc_tcet_comments_final_for_submission.pdf |
